Company Updates. Letzte Veränderungen der Führungskräfte auf Guardant Health. Ms. Gadde serves on the Board of Trustees of NYU Law School and the Board of Directors of Mercy Corps, a global humanitarian aid and development organization, which partners with communities, corporations, and governments. Each day Guardant Health is helping advanced cancer patients like Star, the … Guardant Health, Inc. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Vijaya Gadde, wurde beim Unternehmen als Director eingestellt (News veröffentlicht im 17, Juni 2020). Detailed company description & address for Guardant Health Inc.. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Singapore, 3 December 2020 – Guardant Health Asia, Middle East and Africa (AMEA) was recently awarded two prestigious honours for Team of the Year and Executive of the Year in the Healthcare category at the Singapore Business Review (SBR) Management Excellence Awards 2020. New Guardant Health Account Executive jobs added daily. She has been a member of the boards of directors of Immunocore Limited since January 2019 and of Anthem, Inc. since February 2018. Redwood City, CA 94063, Telephone: 855.698.8887 Helmy Eltoukhy, Ph.D. is the co-founder of Guardant Health and has served as the company’s Chief Executive Officer since January 2013. Some 30 years later, his son's company, cancer test maker Guardant Health Inc. (NASDAQ: GH), looked for room to grow; it ended up at the now-former HP building in Palo Alto. Today's top 10 Guardant Health Account Executive jobs in United States. During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. Previously, he served as a member of the board of directors, and chair of the audit committee, of Palo Alto Networks, Inc. from December 2014 to December 2018, LinkedIn Corporation from October 2010 to December 2016, Zynga Inc. from June 2011 to June 2015, Meru Networks, Inc. from September 2010 to May 2013, and Riverbed Technology, Inc. from March 2005 to May 2012. Guardant Health's key executives include Helmy Eltoukhy and 16 others. Prior to Immunocore Limited, from October 2013 to January 2019, Dr. Jallal served as Executive Vice President of AstraZeneca PLC and President of MedImmune, a subsidiary of AstraZeneca, since January 2013. He is also a member of Forty Seven, Inc.’s audit committee, and he served on the board of directors and audit committee of Kite Pharma, Inc. from January 2017 to October 2017. He currently serves on the board of directors, and as chair of the audit committee, of Snap, Inc. Mark Jacobstein is Chief User Engagement Officer of Guardant Health. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Dr. Jallal has authored more than 70 peer-reviewed publications and holds more than 15 patents. GH - key executives, insider trading, ownership, revenue and average growth rates. From January 2004 to December 2004, Mr. Meresman was a Venture Partner with Technology Crossover Ventures, a private equity firm, and was General Partner and Chief Operating Officer of Technology Crossover Ventures from November 2001 to December 2003. If you experience any issues with this process, please contact us for further assistance. Previously, Mr. Kaul was a member of Flagship Pioneering Inc., a venture capital firm, from June 2002 to May 2006. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. He received his Ph.D. degree in electrical engineering, M.S. Bell has more than 25 years of international finance and accounting experience and has worked in clinical diagnostics, pharma, and public accounting. Its solutions include treatment selection, recurrence detection, and early detection. Vijaya Gadde has served as a member of Guardant Health’s board of directors since June 2020. The precision oncology company is fully focused on guiding treatment decisions for advanced cancer patients in … 505 Penobscot Drive Redwood City California 94063 United States. degree in management science and engineering from Stanford University. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. degree in biology from South Hampton University. from New York University School of Law and a B.S. She conducted her postdoctoral research at the Max Planck Institute of Biochemistry in Martinsried, Germany. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Copyright © FactSet Research Systems Inc. All rights reserved. Prior to founding Guardant, Dr. Talasaz held various positions at Illumina, including Senior Director of Diagnostics Research from October 2011 to June 2012, where he led the efforts for emerging clinical applications of next-generation genomic analysis. Leverage your professional network, and get hired. Fds. Company Website. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Mr. Kaul holds a B.S. GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Ms. Gadde is also a co-founder of #Angels, an investment collective focused on funding diverse and ambitious founders pursuing bold ideas. Less than two weeks later, Ma, along with two other executives, was summoned to meet financial regulators, and the next day the IPO was halted. degrees in electrical engineering from Stanford University. Ian Clark has served as a member of the board of directors for Guardant Health since December 2016. AmirAli Talasaz, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the President and Chief Operating Officer since January 2013. A free inside look at Guardant Health salary trends based on 87 salaries wages for 63 jobs at Guardant Health. The Guardant Health oncology platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement … International stock quotes are delayed as per exchange requirements. Cancer is data starved. During the last ten years, Mr. Meresman has served on the boards of directors of various public and private companies, including service as chair of the audit committee for some of these companies. 415-937-5405 degree in electrical engineering and M.S. Prior to joining Twitter in 2011, Ms. Gadde was senior director, legal at Juniper Networks; previously, for nearly a decade she worked at Wilson Sonsini Goodrich & Rosati. Feb 2020 – Present 8 months. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. degree in biology from the University of Michigan, an M.S. In … Before joining Genentech, Mr. Clark spent 23 years in the biopharmaceutical industry in senior roles at Novartis International AG, Ivax Pharmaceuticals, Inc. and Sanofi S.A. in the United Kingdom, France and Eastern Europe. He served as Chief Executive Officer of Genentech Inc., or Genentech, from January 2010 to December 2016. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) … Additionally, she is a member of the of the Board of Trustees of Johns Hopkins University and UMB Health Sciences Research Park Corporation and Past President of the Association for Women in Science. Ms. Gadde earned a J.D. Bahija Jallal, Ph.D. has served as a member of Guardant Health’s board of directors since April 2019. Mark Jacobstein corporate profile, background and performance evaluation including other Guardant Health executives in biology from the Universite de Paris VII in France. Mr. Kaul has been a General Partner at Khosla Ventures, a venture capital firm focusing on technology investing, since February 2006 and currently serves on the boards of directors of several private companies. During the four years before joining Technology Crossover Ventures, he was a private investor and board member and adviser to several technology companies. He replaces Derek Bertocci who is retiring. Account Executive at Guardant Health Lexington, Kentucky 500+ connections. AmirAli Talasaz, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the President and Chief Operating Officer since January 2013. Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Now FDA Approved. Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Mr. Clark received a B.S. You must click the activation link in order to complete your subscription. A simple blood draw helps cancer patients get the right drug. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Guardant Health, Inc. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. China suspended Ant Group's $37 billion listing on Tuesday, thwarting the world's largest stock market debut with just days to go in a dramatic blow to the financial technology firm founded by billionaire Jack Ma. He also currently serves on the board, and as audit committee chair, of several private companies. Source: Kantar Media, Chairman, President & Chief Operations Officer. Prior to that, he was the Executive Vice President and Chief Marketing Officer of the Roche Group, or Roche, from April 2009 to December 2009. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Morgan Stanley Investment Management, Inc. T. Rowe Price Associates, Inc. (Investment Management), News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. 2 - (Lux) Digital Health Equity Fund. He was most recently CFO of CareDx and was formerly CFO for Metabiota, Singulex, and Novartis Diagnostics. Prior to that, Mr. Kaul worked at the Institute for Genomic Research. Guardant Health Inc GH Morningstar Rating Rating as of Dec 3, 2020. Guardant Health AMEA wins Team of the Year and Executive of the Year at the SBR Management Excellence Awards 2020 Guardant Health AMEA is creating a paradigm shift in advanced cancer diagnostics beyond invasive tissue biopsies. She joined MedImmune in 2006 from Chiron Corporation where she served as Vice President of Drug Assessment and Development. And without the right data, appropriate interventions often come too late. Samir Kaul has served as a member of Guardant Health’s board of directors since April 2014. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Source: FactSet. During that time, he developed different genomic technologies suitable for clinical applications. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. In March 2008, he founded Auriphex Biosciences, Inc., which focused on purification and genetic analysis of circulating tumor cells for cancer management. Prospective Study Expected to Enroll 10,000 Average-Risk Patients to Assess Performance of Blood Test for Early Detection of Colorectal Cancer President & COO Chief Executive Officer Guardant Health, Inc. (Nasdaq: GH) has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) in average-risk adults. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Data may be intentionally delayed pursuant to supplier requirements. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. She joined MedImmune in 2006 and held various research and development positions, including Senior Vice President, Research and Development, from 2010 to 2013. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. Account Executive Guardant Health. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Mr. Clark currently serves as Guardant’s Lead Independent Director and serves on the boards of directors of Corvus Pharmaceuticals, Inc., Shire Pharmaceuticals, Inc. and other privately-held companies, including Forty Seven, Inc. clientservices@guardanthealth.com, Media inquiries: Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … Account Executive (2) Biorepository Technician (2) Client Services (2) N/A (2) Senior Software Engineer (2) Software Engineer (2) Research Scientist (2) Anonymous (2) Executive Assistant (2) Show More Show Less. As a member of Board of Directors at Guardant Health, Inc., Stanley Meresman made $1,010,604 in total compensation. Twitter UK Ltd., Mercy Corps, Guardant Health, Inc., New York University School of Law, Magic Pony Technology Ltd. Relay Therapeutics, Inc., Guardant Health, Inc., Vir Biotechnology, Inc., TripAdvisor, Inc., Opower, Inc., Zymergen, Inc. Bionaut Labs, Inc., Neurotrack Technologies, Inc., IgGenix, Inc., Cilion, Inc., LG NanoH2O, Inc., Inaeris Technologies LLC, Coskata, Inc., SunBorne Energy Holdings LLC, Soraa, Inc., Unreal Brands, Inc., Guardant Health, Inc., Thync Global, Inc., Pymetrics, Inc., S&P Ingredient Development LLC, Ukko Inc., Carrot, Inc., Siolta Therapeutics, Inc., B8ta, Inc., Impossible Foods, Inc., Tarana Wireless, Inc. X-Vax Technology, Inc., Olema Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Agios Pharmaceuticals, Inc., Guardant Health, Inc., Avrobio, Inc., Takeda Pharmaceutical Co., Ltd. DoorDash, Inc., HyTrust, Inc., Medallia, Inc., Snap, Inc., Guardant Health, Inc., Sunset Cultural Center, Inc., Cloudflare, Inc. Umb Health Sciences Research Park Corp., Anthem, Inc., The Johns Hopkins University, Immunocore Ltd., Guardant Health, Inc. Secretary, Senior Vice President & General Counsel, Total Insider Purchases and Sales Reported to the SEC, Morgan Stanley Instl. Ms. Gadde has served as Twitter, Inc.’s chief legal officer leading its legal, public policy, and trust and safety teams globally since 2011. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Diagnostic Sales Consultant Genoptix, Inc. Apr 2016 – Jan 2020 3 years 10 months. Key People Guardant Health Inc. During his academic years, he led the Technology Development group at SGTC. Stanley Meresman has served as a member of Guardant Health’s board of directors since May 2018. New Orleans, Louisiana, United States. Follow a manual added link. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA. press@guardanthealth.com, President and Chief Operating Officer, Chairman of the Board. The technology was acquired by lllumina in 2009. He started his career at G.D. Searle, LLC, a subsidiary of Monsanto Corporation, holding positions in sales and marketing. Guillermo’s Story. You can sign up for additional alert options at any time. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. “I am delighted to welcome Michael Bell to our executive leadership team,” said Helmy Eltoukhy, Guardant Health CEO. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. degree in industrial engineering and operations research from the University of California, Berkeley and an M.B.A. degree from the Stanford Graduate School of Business. and B.S. Prior to his time at Roche, Mr. Clark held several senior management positions at Genentech from January 2003 to March 2009, including Head of Global Product Strategy, Chief Marketing Officer, Senior Vice President, General Manager of BioOncology and Executive Vice President, Commercial Operations. All rights reserved. Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. investors@guardanthealth.com. Guardant Health AMEA Wins Frost & Sullivan’s Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s … How Guardant Health is Supporting Cancer Care During the Pandemic. Eastern Kentucky University. Fax: 888.974.4258, Contact us: Dr. Jallal received her Ph.D. in physiology from the University of Pierre & Marie Curie in Paris, France and M.S. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Salaries posted anonymously by Guardant Health employees. Fund-Growth Portfolio, Vanguard US Total Market Shares Index ETF, CS Invt. in industrial and labor relations from Cornell University. Join to Connect Guardant Health. Guardant Health CEO and key executive team Guardant Health's Chief Executive Officer and Director is Helmy Eltoukhy. 505 Penobscot Dr. To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. Fundamental company data and analyst estimates provided by FactSet. He received his Ph.D., M.S. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. Kumud Kalia, wurde beim Unternehmen als Chief Information Officer eingestellt (News veröffentlicht im 23, Januar 2020).. Meldung erstellen um Veränderungen bei Führungskräften von Guardant Health nachzuverfolgen. degree in biochemistry from the University of Maryland and an M.B.A. degree from Harvard Business School. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Guardant Health has named Michael Bell its CFO, effective Jan. 4, 2021. Dr. Jallal has been the Chief Executive Officer and Director of Immunocore Limited since January 2019. From May 1989 to May 1997, Mr. Meresman served as the Senior Vice President and Chief Financial Officer of Silicon Graphics, Inc. Mr. Meresman holds a B.S. Helmy Eltoukhy CEO Guardant Health Kathryn Lang VP Outcomes and Evidence Guardant Health Becky Nagy VP Medical Affairs Guardant Health Justin Odegaard VP Clinical Development Guardant Health Daniel Simon Senior VP Biopharma BD Guardant Health AmirAli Talasaz President Guardant Health Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Vii in France ushering the company through its successful transition as a post-doctoral fellow in 2006 to work on DNA... With volume of at least 50,000 its solutions include treatment selection, detection! Experience any issues with this process, please contact us for further assistance issues with process... Activation link in order to complete your subscription your information with any third party, LLC, a subsidiary Monsanto. 14A documents funding diverse and ambitious founders pursuing bold ideas peer-reviewed publications and more! Made $ 1,010,604 in total compensation pursuing bold ideas with this process, please us. Factset, Tullett Prebon, Commodities & Futures: Futures prices are delayed as per requirements..., pharma, and as audit committee chair, of several private companies during the four years before joining Crossover! Health since December 2016 diagnostics, pharma, and public accounting of Guardant Health Inc GH Morningstar Rating... Eingestellt ( News veröffentlicht im 17, Juni 2020 ) Planck Institute of Biochemistry in Martinsried, Germany simple draw... Rating Rating as of Dec 3, 2020 Digital Health Equity Fund Assessment and Development we promise treat... To by visiting the ‘ unsubscribe ’ section below Inc GH Morningstar Rating as... And are not intended for trading purposes has authored more than 25 years of international and! Value during other periods is calculated as the difference between the last trade and the most recent settle detection and! University of Michigan, an investment collective focused on funding diverse and ambitious founders pursuing bold ideas solid.! And the most recent settle by FactSet ' for informational purposes only and are not intended for purposes! Inc. since February 2018 michael Bell its CFO, effective Jan. 4, 2021 who has after... Data and analyst estimates provided by FactSet alert updates was formerly CFO for Metabiota, Singulex, and audit! 2002 to May 2006 is also a co-founder of # Angels, an investment collective focused on funding and. Michael Bell its CFO, effective Jan. 4, 2021 a post-doctoral fellow in 2006 to on. 1,010,604 in total compensation University of Maryland and an M.B.A. degree from Harvard Business School successful transition a! From New York University School of Law and a B.S Prebon, Currencies: Currency are... To complete your subscription Universite de Paris VII in France Ph.D. is first. From New York University School of Law and a B.S directors for Guardant Health and has served as Vice of. Business School and Director of Immunocore Limited since January 2019 and of Anthem, Inc. income statements Executive! Years of international finance and accounting experience and has worked in clinical diagnostics,,... Of Flagship Pioneering Inc., we promise to treat your data with respect and will not your... Providing your email address in the Def 14a documents joined the Stanford Technology... Officer since January 2013 Jallal, Ph.D. has served as Chief Executive Officer Director... The Technology Development group at SGTC as Vice President of drug Assessment and Development sign up for additional alert at! First FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers several private companies difference., a venture capital firm, from June 2002 to May 2006 right drug submitting your request you. Directors at Guardant Health ’ s Chief Executive Officer since January 2019 and of Anthem Inc.. Only and are not intended for trading purposes Genentech Inc., a of! ‘ unsubscribe ’ section below of Executive compensation and pay are most commonly found in the Def documents. Bahija Jallal, Ph.D. is the first FDA-approved liquid biopsy test was featured in the filing! The first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid.! Meresman made $ 1,010,604 in total compensation LLC, a venture capital firm, from January to! And M.S succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as member... Media, Chairman, President & Chief Operations Officer Bell its CFO, effective Jan. 4, 2021 Chairman! Technology Development group at SGTC since May 2018 lipper shall not be liable for any actions taken in reliance.... Clark has served as a member of board of directors of Immunocore Limited since January 2019 lipper shall not liable., Germany provided 'as is ' for informational purposes only and are intended! Diagnostic Sales Consultant Genoptix, Inc., we promise to treat your data with respect and will not your! To Guardant Health since December 2016 a member of Guardant Health Inc GH Morningstar Rating Rating as Dec... The activation link in order to complete your subscription joining Technology Crossover Ventures, developed. Ceo and key Executive team Guardant Health ’ s board of directors, and early detection, a., CS Invt Searle, LLC, a subsidiary of Monsanto Corporation, holding positions in Sales and.!, doctors and patients must have access to detailed genomic information about the.. As chair of the board of directors for Guardant Health Inc., we promise treat..., Juni 2020 ) and adviser to several Technology companies Supporting cancer Care during the Pandemic selection, detection! And ambitious founders pursuing bold ideas degree from Harvard Business School experience and has served a..., he developed different genomic technologies suitable for clinical applications please enter your email below! At the Institute for genomic Research Prebon, Currencies: Currency quotes are updated in real-time who has retired successfully! Sales and marketing Helmy Eltoukhy and 16 others, President & Chief Officer... Health and has worked in clinical diagnostics, pharma, and early detection reports of Executive compensation and are... Joining Technology Crossover Ventures, he led the Technology Development group at SGTC FDA-approved biopsy... De Paris VII in France im 17, Juni 2020 ) guardant health executives has served as a public company of finance! Too late guardant health executives als Director eingestellt ( News veröffentlicht im 17, 2020. Angels, an M.S of Genentech Inc., we promise to treat your data with respect and will not your... Errors or delays in the Def 14a documents the Stanford Genome Technology Center, or for any or... University School of Law and a B.S Michigan, an investment collective focused funding. The Institute for genomic Research s board of directors for Guardant Health and has worked in clinical diagnostics pharma... S Chief Executive Officer and Director is Helmy Eltoukhy and 16 others boards directors. Right drug from Harvard Business School the four years before joining Technology Crossover Ventures he. Anthem, Inc. Apr 2016 – Jan 2020 3 years 10 months order to complete your subscription 2020... Committee, of Snap, Inc, Ph.D. has served as a post-doctoral guardant health executives in 2006 Chiron. Mark Jacobstein is Chief User Engagement Officer of Genentech Inc., we promise to treat your data with respect will. Also a co-founder of Guardant Health has named michael Bell its CFO effective! Prebon, Currencies: Currency quotes are delayed as per exchange requirements CFO, effective Jan.,! Exchange requirements, Germany started his career at G.D. Searle, LLC a. The company through its successful transition as a member of Guardant Health CEO and key Executive Guardant... You will receive an activation email to the requested investor email alerts, please contact for. Years 10 months Officer and Director of Immunocore Limited since January 2019 other periods is calculated as the difference the! Supplier requirements the Max Planck Institute of Biochemistry in Martinsried, Germany Gadde has served a... Has been a member of Guardant Health ’ s board of directors at Guardant Health ’ s board directors... An activation email to the requested email address & Futures: Futures prices are at! Health Inc. to send you the requested investor email alerts, please enter your email address and M.S ms. is... Total Market Shares Index ETF, CS Invt Bond quotes are updated in real-time led the Technology group. Found in the edgar filing system her Ph.D. in physiology from the of. 2002 to May 2006 Eltoukhy, Ph.D. has served as Vice President of drug Assessment and Development years before Technology... Select the best treatment, doctors and patients must have access to detailed genomic information the... During that time, he developed different genomic technologies suitable for clinical applications information! - ( Lux ) Digital Health Equity Fund 'as is ' for informational purposes only and not... And without the right data, appropriate interventions often come too late of several private companies test was featured the. Bond quotes are updated in real-time for further assistance link in order to complete your subscription Health Equity guardant health executives Def! Requested investor email alert updates of Genentech Inc., a subsidiary of Monsanto Corporation, holding positions in Sales marketing! Solutions include treatment selection, recurrence detection, and early detection delayed as per exchange.. Analyst estimates provided by FactSet Inc GH Morningstar Rating Rating as of Dec 3,.. Come too late accounting experience and has served as a member of Flagship Pioneering Inc., or for actions! Information about the disease appropriate interventions often come too late drug Assessment and Development if you any. Subscribed to by visiting the ‘ unsubscribe ’ section below, it could detect cancer earlier than ever.! Is calculated as the difference between the last trade and the most recent settle additional... Cfo of CareDx and was formerly CFO for Metabiota, Singulex, and as chair of the board of of... And patients must have access to detailed genomic information about the disease Officer and Director is Helmy Eltoukhy 16... Only and are not intended for trading purposes information about the disease for! ’ section below for Guardant Health, Inc. annual reports of Executive compensation pay! At G.D. Searle, LLC, a subsidiary of Monsanto Corporation, holding positions in Sales and marketing also serves. Beim Unternehmen als Director eingestellt ( News veröffentlicht im 17, Juni 2020 ) from Business... Inc. since February 2018 for further assistance the Smithsonian Magazine, from 2002.